List of Tables
Table 1. Global Cell and Gene Therapy CRO Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Cell and Gene Therapy CRO Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Cell and Gene Therapy CRO Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Cell and Gene Therapy CRO Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Cell and Gene Therapy CRO Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Cell and Gene Therapy CRO Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Cell and Gene Therapy CRO Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Cell and Gene Therapy CRO by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CRO as of 2024)
Table 11. Global Cell and Gene Therapy CRO Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Cell and Gene Therapy CRO Companies Headquarters
Table 13. Global Cell and Gene Therapy CRO Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Cell and Gene Therapy CRO Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Cell and Gene Therapy CRO Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Cell and Gene Therapy CRO Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Cell and Gene Therapy CRO Revenue by Application (2026-2031) & (US$ Million)
Table 21. Cell and Gene Therapy CRO High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Cell and Gene Therapy CRO Growth Accelerators and Market Barriers
Table 25. North America Cell and Gene Therapy CRO Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Cell and Gene Therapy CRO Growth Accelerators and Market Barriers
Table 27. Europe Cell and Gene Therapy CRO Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Cell and Gene Therapy CRO Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Cell and Gene Therapy CRO Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Cell and Gene Therapy CRO Investment Opportunities and Key Challenges
Table 31. Central and South America Cell and Gene Therapy CRO Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Cell and Gene Therapy CRO Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Cell and Gene Therapy CRO Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Labcorp Corporation Information
Table 35. Labcorp Description and Major Businesses
Table 36. Labcorp Product Features and Attributes
Table 37. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Labcorp Revenue Proportion by Product in 2024
Table 39. Labcorp Revenue Proportion by Application in 2024
Table 40. Labcorp Revenue Proportion by Geographic Area in 2024
Table 41. Labcorp Cell and Gene Therapy CRO SWOT Analysis
Table 42. Labcorp Recent Developments
Table 43. IQVIA Biotech Corporation Information
Table 44. IQVIA Biotech Description and Major Businesses
Table 45. IQVIA Biotech Product Features and Attributes
Table 46. IQVIA Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. IQVIA Biotech Revenue Proportion by Product in 2024
Table 48. IQVIA Biotech Revenue Proportion by Application in 2024
Table 49. IQVIA Biotech Revenue Proportion by Geographic Area in 2024
Table 50. IQVIA Biotech Cell and Gene Therapy CRO SWOT Analysis
Table 51. IQVIA Biotech Recent Developments
Table 52. PPD Corporation Information
Table 53. PPD Description and Major Businesses
Table 54. PPD Product Features and Attributes
Table 55. PPD Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. PPD Revenue Proportion by Product in 2024
Table 57. PPD Revenue Proportion by Application in 2024
Table 58. PPD Revenue Proportion by Geographic Area in 2024
Table 59. PPD Cell and Gene Therapy CRO SWOT Analysis
Table 60. PPD Recent Developments
Table 61. Medpace Corporation Information
Table 62. Medpace Description and Major Businesses
Table 63. Medpace Product Features and Attributes
Table 64. Medpace Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Medpace Revenue Proportion by Product in 2024
Table 66. Medpace Revenue Proportion by Application in 2024
Table 67. Medpace Revenue Proportion by Geographic Area in 2024
Table 68. Medpace Cell and Gene Therapy CRO SWOT Analysis
Table 69. Medpace Recent Developments
Table 70. Veristat Corporation Information
Table 71. Veristat Description and Major Businesses
Table 72. Veristat Product Features and Attributes
Table 73. Veristat Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Veristat Revenue Proportion by Product in 2024
Table 75. Veristat Revenue Proportion by Application in 2024
Table 76. Veristat Revenue Proportion by Geographic Area in 2024
Table 77. Veristat Cell and Gene Therapy CRO SWOT Analysis
Table 78. Veristat Recent Developments
Table 79. Parexel Corporation Information
Table 80. Parexel Description and Major Businesses
Table 81. Parexel Product Features and Attributes
Table 82. Parexel Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Parexel Recent Developments
Table 84. Charles River Laboratories Corporation Information
Table 85. Charles River Laboratories Description and Major Businesses
Table 86. Charles River Laboratories Product Features and Attributes
Table 87. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Charles River Laboratories Recent Developments
Table 89. Catalent Pharma Solutions Corporation Information
Table 90. Catalent Pharma Solutions Description and Major Businesses
Table 91. Catalent Pharma Solutions Product Features and Attributes
Table 92. Catalent Pharma Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Catalent Pharma Solutions Recent Developments
Table 94. Premier Research Corporation Information
Table 95. Premier Research Description and Major Businesses
Table 96. Premier Research Product Features and Attributes
Table 97. Premier Research Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Premier Research Recent Developments
Table 99. Catalent Corporation Information
Table 100. Catalent Description and Major Businesses
Table 101. Catalent Product Features and Attributes
Table 102. Catalent Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Catalent Recent Developments
Table 104. Vial Corporation Information
Table 105. Vial Description and Major Businesses
Table 106. Vial Product Features and Attributes
Table 107. Vial Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Vial Recent Developments
Table 109. Noble Life Sciences Corporation Information
Table 110. Noble Life Sciences Description and Major Businesses
Table 111. Noble Life Sciences Product Features and Attributes
Table 112. Noble Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Noble Life Sciences Recent Developments
Table 114. Ergomed Corporation Information
Table 115. Ergomed Description and Major Businesses
Table 116. Ergomed Product Features and Attributes
Table 117. Ergomed Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Ergomed Recent Developments
Table 119. Raw Materials Key Suppliers
Table 120. Distributors List
Table 121. Market Trends and Market Evolution
Table 122. Market Drivers and Opportunities
Table 123. Market Challenges, Risks, and Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Cell and Gene Therapy CRO Product Picture
Figure 2. Global Cell and Gene Therapy CRO Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Preclinical CRO Product Picture
Figure 4. Clinical CRO Product Picture
Figure 5. Global Cell and Gene Therapy CRO Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. SMBs
Figure 7. Large Companies
Figure 8. Cell and Gene Therapy CRO Report Years Considered
Figure 9. Global Cell and Gene Therapy CRO Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 11. Global Cell and Gene Therapy CRO Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Cell and Gene Therapy CRO Revenue Market Share by Region (2020-2031)
Figure 13. Global Cell and Gene Therapy CRO Revenue Market Share Ranking (2024)
Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 15. Preclinical CRO Revenue Market Share by Player in 2024
Figure 16. Clinical CRO Revenue Market Share by Player in 2024
Figure 17. Global Cell and Gene Therapy CRO Revenue Market Share by Type (2020-2031)
Figure 18. Global Cell and Gene Therapy CRO Revenue Market Share by Application (2020-2031)
Figure 19. North America Cell and Gene Therapy CRO Revenue YoY (2020-2031) & (US$ Million)
Figure 20. North America Top 5 Players Cell and Gene Therapy CRO Revenue (US$ Million) in 2024
Figure 21. North America Cell and Gene Therapy CRO Revenue (US$ Million) by Type (2020 - 2031)
Figure 22. North America Cell and Gene Therapy CRO Revenue (US$ Million) by Application (2020-2031)
Figure 23. US Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 24. Canada Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 25. Mexico Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 26. Europe Cell and Gene Therapy CRO Revenue YoY (2020-2031) & (US$ Million)
Figure 27. Europe Top 5 Players Cell and Gene Therapy CRO Revenue (US$ Million) in 2024
Figure 28. Europe Cell and Gene Therapy CRO Revenue (US$ Million) by Type (2020-2031)
Figure 29. Europe Cell and Gene Therapy CRO Revenue (US$ Million) by Application (2020-2031)
Figure 30. Germany Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 31. France Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 32. U.K. Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 33. Italy Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 34. Russia Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Cell and Gene Therapy CRO Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Top 8 Players Cell and Gene Therapy CRO Revenue (US$ Million) in 2024
Figure 37. Asia-Pacific Cell and Gene Therapy CRO Revenue (US$ Million) by Type (2020-2031)
Figure 38. Asia-Pacific Cell and Gene Therapy CRO Revenue (US$ Million) by Application (2020-2031)
Figure 39. Indonesia Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 40. Japan Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 41. South Korea Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 42. Australia Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 43. India Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 44. Indonesia Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 45. Vietnam Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 46. Malaysia Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 47. Philippines Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 48. Singapore Cell and Gene Therapy CRO Revenue (2020-2031) & (US$ Million)
Figure 49. Central and South America Cell and Gene Therapy CRO Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Central and South America Top 5 Players Cell and Gene Therapy CRO Revenue (US$ Million) in 2024
Figure 51. Central and South America Cell and Gene Therapy CRO Revenue (US$ Million) by Type (2020-2031)
Figure 52. Central and South America Cell and Gene Therapy CRO Revenue (US$ Million) by Application (2020-2031)
Figure 53. Brazil Cell and Gene Therapy CRO Revenue (2020-2025) & (US$ Million)
Figure 54. Argentina Cell and Gene Therapy CRO Revenue (2020-2025) & (US$ Million)
Figure 55. Middle East and Africa Cell and Gene Therapy CRO Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa Top 5 Players Cell and Gene Therapy CRO Revenue (US$ Million) in 2024
Figure 57. South America Cell and Gene Therapy CRO Revenue (US$ Million) by Type (2020-2031)
Figure 58. Middle East and Africa Cell and Gene Therapy CRO Revenue (US$ Million) by Application (2020-2031)
Figure 59. GCC Countries Cell and Gene Therapy CRO Revenue (2020-2025) & (US$ Million)
Figure 60. Israel Cell and Gene Therapy CRO Revenue (2020-2025) & (US$ Million)
Figure 61. Egypt Cell and Gene Therapy CRO Revenue (2020-2025) & (US$ Million)
Figure 62. South Africa Cell and Gene Therapy CRO Revenue (2020-2025) & (US$ Million)
Figure 63. Cell and Gene Therapy CRO Industry Chain Mapping
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
